CIA
ABBV icon

Cape Investment Advisory’s AbbVie ABBV Stock Holding History

Cape Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Sell
1,417
-18
-1% -$3.87K 0.1% 157
2026
Q1 		$312K Buy
1,435
+61
+4% +$13.5K 0.1% 170
2025
Q4 		$314K Buy
1,374
+1,120
+441% +$255K 0.1% 160
2025
Q3 		$58.8K Sell
254
-1,195
-82% -$243K 0.06% 210
2025
Q2 		$269K Sell
1,449
-144
-9% -$26.8K 0.1% 159
2025
Q1 		$334K Sell
1,593
-19
-1% -$3.69K 0.13% 122
2024
Q4 		$286K Buy
1,612
+224
+16% +$41.2K 0.11% 137
2024
Q3 		$274K Sell
1,388
-38
-3% -$7.09K 0.11% 132
2024
Q2 		$245K Sell
1,426
-108
-7% -$17.9K 0.11% 131
2024
Q1 		$279K Sell
1,534
-78
-5% -$13.4K 0.13% 119
2023
Q4 		$250K Buy
1,612
+80
+5% +$11.7K 0.12% 123
2023
Q3 		$228K Sell
1,532
-88
-5% -$12.9K 0.13% 118
2023
Q2 		$218K Buy
1,620
+49
+3% +$7.18K 0.12% 122
2023
Q1 		$250K Buy
+1,571
New +$240K 0.15% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cape Investment Advisory's ABBV Position: Q2 2026 in Review

Cape Investment Advisory reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $3.87K and leaving 1,417 shares worth $357K. The position accounts for 0.1% of the portfolio, ranked #157.

Cape Investment Advisory first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cape Investment Advisory held 1,417 shares of AbbVie worth $357K as of Q2 2026.
  • Cape Investment Advisory sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.1% of Cape Investment Advisory's portfolio in Q2 2026, its #157 holding.
  • Cape Investment Advisory first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.